Categories Earnings, Technology

FireEye posts 8% jump in Q1 revenue

Cybersecurity company FireEye (FEYE) reported an 8% jump in first quarter revenue to $199 million, higher than the guidance range of $192 million to $197 million. The company’s billings, one of the key indicators for future growth, jumped 21% year-over-year to $175.1 million.

This improvement is significant as a slowdown in billings had troubled the company for many quarters. Billings narrowly beat the forecast of $165 million to $175 million.

However, following the earnings release, the FireEye stock fell 5.66% in after hours trading.

Net loss for the quarter narrowed to $0.39 per share, compared to $0.45 in the first quarter of 2017. On an adjusted basis, the company reported a loss of 4 cents a share during the quarter.

FireEye Q1 2018 Earnings

This improvement is significant as a slowdown in billings had troubled the company for many quarters. Billings narrowly beat the forecast of $165 million to $175 million.

“We also continued to drive innovation across our product portfolio, added new features and functionality, and updated our pricing and packaging,” said Kevin Mandia, CEO.

FireEye had introduced new business strategies in an attempt to revive its growth. It appears that the company is finally reaping benefits of its long-drawn transformation that included layoffs also.

The California-based firm predicts its 2018 sales to be around $820 million to $830 million, close to a 10% annual jump. Billings are expected to be in the range of $815 million to $835 million. The company expects its adjusted earnings to be around $0.00 to $0.04.

For the upcoming June quarter, the company expects revenue of $199 million to $203 million, billings of $180 million to $195 million and adjusted net income (loss) per share of $(0.03) to $0.00.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top